Journals / Türk Kardiyoloji Derneği Arşivi / 2008 / Cilt: 36 - Sayı: 7

Does accompanying metabolic syndrome contribute to heart dimensions in hypertensive patients?

Hipertansiyonlu hastalarda metabolik sendrom varlığının kalp boyutlarına katkısı var mıdır?

Pages
446–450
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Compared to the control group, patients with or without MetS exhibited significantly increased interventricular septum and posterior wall thickness, left atrial diameter, relative wall thickness, and left ventricular mass (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Metabolic syndrome (MetS) is associated with increased risk for cardiovascular events.
📊
Key Findings & Data:Study design: The study included 75 hypertensive patients (34 males, 41 females; mean age 51±9 years) without coronary artery disease.
💡
Conclusion & Impact:Compared to the control group, patients with or without MetS exhibited significantly increased interventricular septum and posterior wall thickness, left atrial diameter, relative wall thickness, and left ventricular mass (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Metabolic syndrome (MetS) is associated with increased risk for cardiovascular events. We evaluated heart dimensions in hypertensive patients with MetS. Study design: The study included 75 hypertensive patients (34 males, 41 females; mean age 51±9 years) without coronary artery disease. Patients were evaluated in two groups depending on the presence or absence of MetS. Age and gender-matched 20 healthy subjects (9 males, 11 females; mean age 50±5 years) comprised the control group. The diagnosis of MetS was based on the presence of at least three of five MetS criteria. Hypertension was defined as arterial blood pressure exceeding 140/85 mmHg on three consecutive measurements or the use of antihypertensive drugs. Echocardiographic measurements included interventricular septal thickness, left ventricular internal diameter, posterior wall thickness, aortic diameter, left atrial diameter, relative wall thickness, and left ventricular mass. Results: Metabolic syndrome was present in 32 hypertensive patients (42.7%; 18 males, 14 females). The mean number of MetS criteria was 2.6±1.0 in the hypertensive group. Compared to the control group, patients with or without MetS exhibited significantly increased interventricular septum and posterior wall thickness, left atrial diameter, relative wall thickness, and left ventricular mass (p

Özet

Amaç: Metabolik sendrom (MetS) kardiyovasküler olay riskini artırmaktadır. Bu çalışmada hipertansiyonla birlikte MetS olan hastalarda kalp boyutları değerlendirildi. Ça lış ma pla nı: Çalışmaya koroner arter hastalığı olmayan 75 hipertansif hasta alındı (34 erkek, 41 kadın; ort. yaş 51±9). Hastalar, hipertansiyonla birlikte MetS olup olmamasına göre iki gruba ayırıldı. Yaş ve cinsiyet uyumlu 20 sağlıklı birey (9 erkek, 11 kadın; ort. yaş 50±5) kontrol grubunu oluşturdu. Metabolik sendrom tanısı beş tanı ölçütünden üçünün varlığında kondu. Hipertansiyon tanısı, ardışık üç ölçümde arteryel kan basıncının 140/85 mm Hg üzerinde olması veya antihipertansif tedavi varlığına dayandırıldı. Ekokardiyografik incelemede interventriküler septal kalınlık, sol ventrikül iç çapı, sol ventrikül arka duvar kalınlığı, aort çapı, sol atriyum çapı, nispi duvar kalınlığı ve sol ventrikül kütlesi ölçüldü. Bul gu lar: Hipertansif hastaların 32’sinde (%42.7; 18 erkek, 14 kadın) MetS saptandı. Tüm hipertansiflerde ortalama MetS ölçüt sayısı 2.6±1.0 bulundu. Metabolik sendrom olan ve olmayan hastalarda interventriküler septum ve arka duvar kalınlığı, sol atriyum çapı, nispi duvar kalınlığı ve sol ventrikül kütlesi kontrol grubuna göre daha fazla idi (p

🔖

Cite This Article

UZUN, M., ULUSOY, E., KILIÇASLAN, F., CEBECİ, B. S., SAĞ, C., KIRILMAZ, A., BAYSAN, O., YILDIRIM, M., YOKUŞOĞLU, M., KÖZ, C. (2022). Does accompanying metabolic syndrome contribute to heart dimensions in hypertensive patients?. Türk Kardiyoloji Derneği Arşivi, Cilt: 36 - Sayı: 7, 446–450. https://ajindex.com/articles/633488

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-8
  2. Sundstrom J, Arnlov J, Stolare K, Lind L. Blood pressure independent relations of left ventricular geometry to the metabolic syndrome and insulin resistance: a population-based study. Heart 2008;94:874-8
  3. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975;56:56-64
  4. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991;114:345-52
  5. Majahalme S, Turjanmaa V, Weder A, Lu H, Tuomisto M, Virjo A, et al. Blood pressure levels and variability, smoking, and left ventricular structure in normotension and in borderline and mild hypertension. Am J Hypertens 1996;9:1110-8
  6. Meredith PA, Ostergren J. From hypertension to heart failure - are there better primary prevention strategies? J Renin Angiotensin Aldosterone Syst 2006;7:64-73
  7. Chinali M, Devereux RB, Howard BV, Roman MJ, Bella JN, Liu JE, et al. Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study). Am J Cardiol 2004;93:40-4
  8. Lind L, Andersson PE, Andren B, Hanni A, Lithell HO. Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome. J Hypertens 1995;13:433-8
  9. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977;55:613-8
  10. Azevedo A, Bettencourt P, Almeida PB, Santos AC, Abreu-Lima C, Hense HW, et al. Increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities-cross-sectional study of the general population. BMC Cardiovasc Disord 2007;7:17
  11. Uzun M, Sağ C, Özkan M, Baysan O, Erinç K, Yokuşoğlu M ve ark. Mitral kapak prolapsuslu hastalarda kalp hızı değişkenliği ve sol ventrikül geometrisi arasındaki ilişki. Gülhane Tıp Dergisi 2005;47:260-4
  12. Uzun M, Baysan O, Kırılmaz A, Sağ C, Köz C, Erinç K ve ark. İskemik kalp hastalığı tanısında diyastolik fonksiyona ait doku Doppler ekokardiyografi pa